- Moderna filed for FDA authorization of a third-dose booster shot of its COVID-19 vaccine; and a recent study found that the Moderna vaccine produces more antibodies than the Pfizer/BioNTech vaccine.
- A study in Israel showed the COVID-19 booster shot effectively protects recipients from severe infection.
- Pfizer announced a clinical trial of a pill with potential to treat COVID-19. In addition, a recent study finds Pfizer/BioNTech to be safe for highly allergic persons.
- State licensing waivers for telemedicine across state borders are beginning to expire.
White House and Federal Agencies
- The Department of Health and Human Services (HHS) Office of Inspector General (OIG) issued a report on the types of conditions for which Medicare beneficiaries with COVID-19 were being treated and who was more likely to be hospitalized with COVID-19. This report is intended to help hospitals and health officials better prepare for and address the wide-ranging and extensive needs of COVID-19 patients.
Economy, Vaccines, Testing and Treatment
- Moderna filed for FDA authorization of a third-dose booster shot of its COVID-19 vaccine.
- The Centers for Disease Control and Prevention (CDC) reports nearly 1 million Americans have received a third dose of the COVID-19 vaccine.
- Members of the CDC’s Advisory Committee on Immunization Practices (ACIP) voiced differing views about booster doses of the COVID-19 vaccine. ACIP’s recommendations are influential but non-binding.
- A study in Israel showed the COVID-19 booster shot effectively protects recipients from severe infection.
- The World Health Organization (WHO) is monitoring a new COVID-19 variant called “mu.”
- CDC director Dr. Rochelle Walensky advised the unvaccinated against travel on Labor Day.
- A recent study concluded that vaccination incentive programs did not significantly increase vaccination rates.
- The impact of the recent FDA approval of Pfizer/BioNTech on unvaccinated adults remains unclear. Some surveys show it improves confidence in the vaccine while others show continued hesitancy among unvaccinated people. Another survey suggests vaccination rates will increase if it is required to attend concerts or sporting events.
- Pfizer announced a clinical trial of a pill with potential to treat COVID-19.
- Over 15.1 million doses of the COVID-19 vaccine have been thrown out since March of 2021.
- A recent study finds the Pfizer/BioNTech vaccine to be safe for highly allergic persons.
- CDC reports people are 16 times more likely to experience myocarditis from COVID-19 infection than as a side effect of the COVID-19 vaccine.
- State licensing waivers for telemedicine across state borders are beginning to expire.
Centers for Disease Control and Prevention (CDC) Updates
- The CDC published the following reports and website updates:
- Overall U.S. COVID-19 Vaccine Distribution and Administration Update as of Thu, 02 Sep 2021 06:00:00 EST
- Cases in the U.S.
- COVID-19 Vaccination Coverage Among Adolescents Aged 12–17 Years — United States, December 14, 2020–July 31, 2021
- Selected Adverse Events Reported after COVID-19 Vaccination
- Reporting COVID-19 Vaccination Demographic Data
- COVID-19 Vaccine Booster Shot
- Safer Travel Tips for Families with Unvaccinated Children
- Frequently Asked Questions about COVID-19 Vaccination
- CDC launches COVID-19 resources for people with intellectual and developmental disabilities
- Schools and Childcare Programs
- COVID-19 Vaccine Reporting Systems
